These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6483073)

  • 1. [Renal toxicity of 9-hydroxy-2-methyl-ellipticinium].
    Ryckelynck JP; Heron JF; Juret P; Schneider P; Herlin P; De Ranieri E; Hardouin A; Peny J; Le Talaer JY
    Nephrologie; 1984; 5(2):59-63. PubMed ID: 6483073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experience.
    Juret P; Heron JF; Couette JE; Delozier T; Le Talaer JY
    Cancer Treat Rep; 1982 Nov; 66(11):1909-16. PubMed ID: 7139636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hydroxy-9-methyl-2-ellipticinium (NSC 264-137) for osseous metastases from breast cancer. A 4 year experience (author's transl)].
    Juret P; Couette JE; Delozier T; Le Talaer JY
    Bull Cancer; 1981; 68(3):224-31. PubMed ID: 7039729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
    Rouesse J; Tursz T; Le Chevalier T; Huertas D; Amiel JL; Brule G; Callet B; Droz JP; Voisin PM; Sancho-Garnier H; Le Pecq JB; Paoletti C
    Nouv Presse Med; 1981 May; 10(24):1997-9. PubMed ID: 7255136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of elliptinium in advanced breast cancer.
    Rouësse JG; Le Chevalier T; Caille P; Mondesir JM; Sancho-Garnier H; May-Levin F; Spielmann M; De Jager R; Amiel JL
    Cancer Treat Rep; 1985 Jun; 69(6):707-8. PubMed ID: 4016774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)].
    Juret P; Tanguy A; Girard A; Le Talaer JY; Abbatucci JS; Dat-Yuong ; Le Pecq JB; Paoletti C
    Nouv Presse Med; 1979 Apr; 8(18):1495-8. PubMed ID: 471724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)].
    Rouëssé J; Huertas D; Sancho-Garnier H; Le Chevalier T; Amiel JL; Brulé G; Tursz T; Mondésir JM
    Bull Cancer; 1981; 68(5):437-41. PubMed ID: 7037078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxy-9-methyl-2-Ellipticinium (NSC 264-137) in 52 cases of osseous metastases from breast cancer.
    Juret P; Le Talaer Y; Couette JE; Delozier T
    Eur J Cancer (1965); 1980; Suppl 1():277-9. PubMed ID: 7032940
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-Methyl-9-hydroxyellipticinium acetate (ellipticinium) in the treatment of lymphomas. Preliminary results of a phase II study.
    Tura S; Mandelli F; Mazza P; Cimino G; Anselmo AP; Amadori S
    Chemioterapia; 1984 Apr; 3(2):79-82. PubMed ID: 6532540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast.
    Sternberg CN; Yagoda A; Casper E; Scoppetuolo M; Scher HI
    Anticancer Res; 1985; 5(4):415-7. PubMed ID: 4037737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal toxicity of 9-hydroxy-2-methylellipticinium].
    Ryckelynck JP; Heron JF; Juret P; De Ranieri E; Herlin P; Hardouin A; Le Talaer JY
    Presse Med; 1984 Jan; 13(2):104. PubMed ID: 6229731
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine and human renal toxicity of inosine dialdehyde (NSC 118994).
    Kaufman J; Keogh B; Mittelman A; Wallens T; Murphy GP
    J Med; 1977; 8(3-4):239-51. PubMed ID: 267714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of alpha-Methyldopa Sesquihydrate (CAS No. 41372-08-1) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Mar; 348():1-184. PubMed ID: 12704436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrate-induced deterioration of renal function].
    Polanco N; Hernández E; González E; Gutiérrez Martínez E; Bello I; Gutiérrez-Millet V; García F; Morales E; Praga M
    Nefrologia; 2009; 29(3):208-13. PubMed ID: 19554053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).
    Paoletti C; Le Pecq JB; Dat-Xuong N; Juret P; Garnier H; Amiel JL; Rouesse J
    Recent Results Cancer Res; 1980; 74():107-23. PubMed ID: 7003658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal toxicity of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate in the Wistar rat.
    Raguenez-Viotte G; Dadoun C; Buchet P; Ducastelle T; Fillastre JP
    Arch Toxicol; 1988; 61(4):292-7. PubMed ID: 3377684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
    de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A
    Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.